Answers are grounded in this paper and cite their sources.
Glycosylated 4-amino-1,8-naphthalimide derivatives possess a native glycosidic linkage that can be selectively hydrolysed in situ by glycosidase enzymes to release the naphthalimide as a fluorescent imaging or therapeutic agent. In vitro studies using a variety of cancer cell lines demonstrated that the naphthalimides only get taken up into cells upon enzymatic cleavage from the glycan unit; a mechanism that offers a novel approach for the targeted delivery of probes/drugs.
No takes yet. Share an insight, caveat, or question.
Calatrava‐Pérez et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: